Gemcitabine combined with cisplatin as adjuvant chemotherapy for non‐small cell lung cancer: A retrospective analysis

BACKGROUND: This study was conducted to evaluate the value of gemcitabine combined with cisplatin as adjuvant chemotherapy for radical resection of non‐small cell lung cancer. METHODS: Data of 100 patients who had undergone radical resection of non‐small cell lung cancer and were treated with cispla...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Di, Wang, Jing, Hao, Xuezhi, Wang, Yan, Hu, Xingsheng, Xing, Puyuan, Li, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582465/
https://www.ncbi.nlm.nih.gov/pubmed/28745824
http://dx.doi.org/10.1111/1759-7714.12472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582465/
https://www.ncbi.nlm.nih.gov/pubmed/28745824
http://dx.doi.org/10.1111/1759-7714.12472

Ejemplares similares